Mochida Pharmaceutical Co., Ltd. (TYO:4534)

Japan flag Japan · Delayed Price · Currency is JPY
3,665.00
+15.00 (0.41%)
Jan 21, 2026, 3:30 PM JST
11.74%
Market Cap129.92B
Revenue (ttm)109.05B
Net Income (ttm)6.72B
Shares Out35.45M
EPS (ttm)189.45
PE Ratio19.35
Forward PEn/a
Dividend80.00 (2.19%)
Ex-Dividend DateMar 30, 2026
Volume29,500
Average Volume36,820
Open3,625.00
Previous Close3,650.00
Day's Range3,620.00 - 3,665.00
52-Week Range2,836.00 - 3,725.00
Beta-0.10
RSI63.14
Earnings DateFeb 6, 2026

About Mochida Pharmaceutical

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia; Treprost for the treatment of pulmonary arterial hypertension and p... [Read more]

Sector Healthcare
Founded 1913
Employees 1,508
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4534
Full Company Profile

Financial Performance

In 2024, Mochida Pharmaceutical's revenue was 105.16 billion, an increase of 2.21% compared to the previous year's 102.89 billion. Earnings were 5.69 billion, an increase of 25.03%.

Financial Statements